Trandolapril/verapamil combination in hypertensive diabetic patients

References

• AdlerAIStrattonIMNeilHAAssociation of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational studyBMJ20003214121910938049
   PubMed Web of Science ®Google Scholar
• BakrisGLWeirMRDeQuattroVEffects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathyKidney Int199854128399767545
   PubMed Web of Science ®Google Scholar
• BakrisGLWilliamsMDworkinLfor the National Kidney Foundation Hypertension and Diabetes Executive Committees Working GroupPreserving renal function in adults with hypertension and diabetes: a consensus approachAm J Kidney Dis2000366466110977801
   PubMed Web of Science ®Google Scholar
• BakrisGLGaxiolaEMesserliFHClinical outcomes in the diabetes cohort of the INternational VErapamil SR-Trandolapril studyHypertension2004446374215381674
   PubMed Web of Science ®Google Scholar
• BrennerBMCooperMEde ZeeuwDEffects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathyN Engl J Med2001345861911565518
   PubMed Web of Science ®Google Scholar
• CifkovaRNakovRNovozamskaEEvaluation of the effects of fixed combinations of sustained-release verapamil/trandolapril versus captopril/hydrochlorothiazide on metabolic and electrolyte parameters in patients with essential hypertensionJ Hum Hypertens2000143475410878692
   PubMed Web of Science ®Google Scholar
• CurbJDPresselSLCutlerJAEffect of diuretic-based anti-hypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research GroupJAMA19962761886928968014
   PubMed Web of Science ®Google Scholar
• [ESH–ESC] European Society of Hypertension–European Society of Cardiology guidelines for the management of arterial hypertensionJ Hypertens20032110115312777938
   PubMed Web of Science ®Google Scholar
• FernandezRPuigJGRodriguez-PerezJCTRAVEND Study GroupEffect of two antihypertensive combinations on metabolic control in type 2 diabetic hypertensive patients with albuminuria: a randomized, double-blind studyJ Hum Hypertens2001158495611773987
   PubMed Web of Science ®Google Scholar
• HanefeldMFischerSJuliusURisk factors for myocardial infarction and death in newly detected NIDDM: the diabetes intervention study, 11-year follow-upDiabetologia1996391577838960845
   PubMed Web of Science ®Google Scholar
• HanssonLZanchettiACarruthersSGEffects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trialLancet19983511755629635947
   PubMed Web of Science ®Google Scholar
• HillemanDERyschonKLMohiuddinSMFixed-dose combinations versus monotherapy in hypertension: a meta-analysis evaluationJ Hum Hypertens1999134778310449213
   PubMed Web of Science ®Google Scholar
• [HOPE] Heart Outcomes Prevention Evaluation Study InvestigatorsEffects of an angiotensin-converting–enzyme inhibitor, ramipril, on cardiovascular events in high-risk patientsN Engl J Med20003421455310639539
   PubMed Web of Science ®Google Scholar
• [HOPE] Heart Outcomes Prevention Evaluation (HOPE) Study investigatorsEffects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudyLancet2000a3552539
   PubMed Web of Science ®Google Scholar
• [HDS] Hypertension in Diabetes Study Group (HDS)Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardio-vascular and diabetic complicationsJ Hypertens199311309178387089
   PubMed Web of Science ®Google Scholar
• JarrettJRFitzgeraldAPNon-insulin-dependent diabetes mellitus, glucose intolerance, blood pressure, hypertension and antihypertensive drugsDiabet Med19941164697955988
   PubMed Web of Science ®Google Scholar
• [JNC] The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: The JNC 7 ReportJAMA200328925607212748199
   PubMed Web of Science ®Google Scholar
• KannelWMcGeeDDiabetes and cardiovascular disease. The Framingham StudyJAMA197924120358430798
   PubMed Web of Science ®Google Scholar
• KleinRHyperglycaemia and microvascular and microvascular disease in diabetesDiabetes Care199518258687729308
   PubMed Web of Science ®Google Scholar
• KnuimanMWWelbornTAMcCannVJPrevalence of diabetic complications in relation to risk factorsDiabetes198635133293770311
   PubMed Web of Science ®Google Scholar
• LehtoSRonnemaaTHaffnerSMDyslipidemia and hyperglycaemia predict coronary heart disease events in middle-aged patients with NIDDMDiabetes199746135499231662
   PubMed Web of Science ®Google Scholar
• LewisEJHunsickerLGClarkeWRRenoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetesN Engl J Med20013458516011565517
   PubMed Web of Science ®Google Scholar
• MacMahonSPetoRCutlerJBlood pressure, stroke, and coronary heart disease. Part 1. Prolonged difference in blood pressure: prospective observational studies corrected for the regression dilution biasLancet1990335765741969518
   PubMed Web of Science ®Google Scholar
• MuijsersBRCurranMPerryCFixed combination trandolapril/verapamil sustained releaseDrugs2002622539612421112
   PubMed Web of Science ®Google Scholar
• OliveiraSALapuertaPMcCarthyBDPhysician-related barriers to the effective management of uncontrolled hypertensionArch Intern Med20021624132011863473
   PubMedGoogle Scholar
• ParvingHHLehnertHBröchner-MortensenJThe effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetesN Engl J Med2001345870811565519
   PubMed Web of Science ®Google Scholar
• PepineCHandbergECooper-DeHofffor the INVEST investigatorsA calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trialJAMA200329028051614657064
   PubMed Web of Science ®Google Scholar
• PROCOPA study groupDissociation between blood pressure reduction and fall in proteinuria in primary renal disease: a randomized double-blind trialJ Hypertens2002207293711910310
   PubMed Web of Science ®Google Scholar
• RavidMSavinHJutrinILong-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and in on proteinuria in normotensive type 2 diabetic patientsAnn Intern Med1993118577818452322
   PubMed Web of Science ®Google Scholar
• RuggenentiPFassiAIlievaAPBergamo Nephrologic Diabetes Complications Trial (BENEDICT) investigatorsPreventing microalbuminuria in type 2 diabetesN Engl J Med200435119415115516697
   PubMed Web of Science ®Google Scholar
• RuilopeLMde la SierraAMorenoEProspective comparison of therapeutical attitudes in hypertensive type 2 diabetic patients uncontrolled on monotherapyJ Hypertens19991719172310703890
   PubMed Web of Science ®Google Scholar
• RuilopeLMSalvettiAJamersonKRenal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) studyJ Am Soc Nephrol2001122182511158211
   PubMed Web of Science ®Google Scholar
• RuilopeLMUsanLSeguraJIntervention at lower blood pressure levels to achieve target goals in type 2 diabetes: PRADID (PResión Arterial en Diabéticos tipo Dos) studyJ Hypertens2004222172215106814
   PubMed Web of Science ®Google Scholar
• SchrierRWEstacioROEslerAEffects of aggressive blood pressure control on normotensive type 2 diabetic patients on albuminuria, retinopathy and strokesKidney Int200265110869711849464
   PubMedGoogle Scholar
• SowersJPSowersPSPeulerJDRole of insulin resistance and hiperinsulinemia in development of hypertension and atherosclerosisJ Lab Clin Med1994123647528195670
   PubMed Web of Science ®Google Scholar
• TeuscherAWeidmannPRequirements for antihypertensive therapy in diabetic patients: metabolic aspectsJ Hypertens199715Suppl 2S67S75
   Google Scholar
• TuomilehtoJRastenyteDBirkenhägerWHEffects of calcium-channel blockade in older patients with diabetes and systolic hypertensionN Engl J Med19993406778410053176
   PubMed Web of Science ®Google Scholar
• VasanRSLarsonMGLeipEPImpact of high-normal blood pressure on the risk of cardiovascular disease. Framingham Heart StudyN Engl J Med200134512911211794147
   PubMed Web of Science ®Google Scholar
• ZanchettiARuilopeLMAntihypertensive treatment in patients with type 2 diabetes mellitus: what guidance from recent controlled randomized trialsJ Hypertens200220209911012409940
   PubMed Web of Science ®Google Scholar